Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D White

Showing results (81-90 of 301) with videos related to

Pageof 31
Sort By:
European Heart Journal|August 1, 1990
Left ventricular function as an end-point of thrombolytic therapyR M Norris, H D White
European Heart Journal|April 30, 2002
Has the mortality rate from acute myocardial infarction fallen substantially in recent years?C-K Wong, H D White
Journal of Thrombosis and Thrombolysis|September 29, 1999
Antithrombin agents as adjuncts to thrombolytic therapyJ K French, H D White
The New Zealand Medical Journal|August 11, 1995
A direct threat to research in public hospitalsJ M Neutze, H D White
Clinical and Experimental Pharmacology & Physiology|March 1, 1995
Left ventricular function following thrombolytic therapy for myocardial infarctionJ K French, H D White
Biochemistry|December 28, 1976
Energetics and mechanism of actomyosin adenosine triphosphataseH D White, E W Taylor
The New Zealand Medical Journal|October 12, 1994
Ischaemic heart diseaseG P Armstrong, H D White
The New Zealand Medical Journal|October 11, 1996
Comparing health expenditureJ M Neutze, H D White
Lancet (London, England)|September 16, 1989
Left-ventricular function as an end-pointH D White, R M Norris
The Journal of Biological Chemistry|May 15, 1993
Kinetics of binding and hydrolysis of a series of nucleoside triphosphates by actomyosin-S1. Relationship between solution rate constants and properties of muscle fibersH D White, B Belknap, W Jiang
Pageof 31

Showing results (81-90 of 301) with videos related to

Sort By:
Pageof 31
European Heart Journal|August 1, 1990
Left ventricular function as an end-point of thrombolytic therapyR M Norris, H D White
European Heart Journal|April 30, 2002
Has the mortality rate from acute myocardial infarction fallen substantially in recent years?C-K Wong, H D White
Journal of Thrombosis and Thrombolysis|September 29, 1999
Antithrombin agents as adjuncts to thrombolytic therapyJ K French, H D White
The New Zealand Medical Journal|August 11, 1995
A direct threat to research in public hospitalsJ M Neutze, H D White
Clinical and Experimental Pharmacology & Physiology|March 1, 1995
Left ventricular function following thrombolytic therapy for myocardial infarctionJ K French, H D White
Biochemistry|December 28, 1976
Energetics and mechanism of actomyosin adenosine triphosphataseH D White, E W Taylor
The New Zealand Medical Journal|October 12, 1994
Ischaemic heart diseaseG P Armstrong, H D White
The New Zealand Medical Journal|October 11, 1996
Comparing health expenditureJ M Neutze, H D White
Lancet (London, England)|September 16, 1989
Left-ventricular function as an end-pointH D White, R M Norris
The Journal of Biological Chemistry|May 15, 1993
Kinetics of binding and hydrolysis of a series of nucleoside triphosphates by actomyosin-S1. Relationship between solution rate constants and properties of muscle fibersH D White, B Belknap, W Jiang
Pageof 31